Study on the possible hepatoprotive effect of certain drugs against ischemia/reperfusion liver injury in rats / Abdallah Mohammed Said Ahmed Gendy ; Supervised Hanan Salaheldin Elabhar , Rania Mohsen Abdelsalam
Material type:
TextLanguage: English Publication details: Cairo : Abdallah Mohammed Said Ahmed Gendy , 2014Description: 167 P. : charts ; 25cmOther title: - التأثير الكبدى الوقائى المحتمل لبعض الأدوية ضد الدم فى كبد الجرزان المتبوع بإعادة التروية [Added title page title]
- Issued also as CD
| Item type | Current library | Home library | Call number | Copy number | Status | Barcode | |
|---|---|---|---|---|---|---|---|
Thesis
|
قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.08.09.M.Sc.2014.Ab.S (Browse shelf(Opens below)) | Not for loan | 01010110064673000 | ||
CD - Rom
|
مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.08.09.M.Sc.2014.Ab.S (Browse shelf(Opens below)) | 64673.CD | Not for loan | 01020110064673000 |
Thesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Pharmacology and Toxicology
Cilostazol is an antiplatelet that acts by inhibiting phosphodiesterase-3 and that was proven to be effective in models of ischemia/reperfusion (I/R) injury; however, its possible role in hepatic 1/R remains indistinct, which is the aim of the current work. cilostazol potential effect was compared to known ani-ischemic drug trimetazidine, which is used as an antianginal drug and that protects heart and liver against 1/R. to fulfill the goal, rats were randomized into sham, 1/R, cilostazol (60mg/Kg, p.o) and trimetazidine (20mg/kg, p.o) groups
Issued also as CD
There are no comments on this title.
Click on an image to view it in the image viewer